Your SlideShare is downloading. ×
  • Like
  • Save
Wyeth Remake Analyst Meeting 10-05-06 slides 4-8
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Wyeth Remake Analyst Meeting 10-05-06 slides 4-8

  • 742 views
Published

 

Published in Business , Economy & Finance
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
742
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Remake of October 5, 2006 Wyeth Analyst Meeting slides 4-8 http://phx.corporate-ir.net/phoenix.zhtml?c=78193&p=irol-presentations
  • 2. Agenda 4 Break New Products U. Wiinberg Enbrel® & Prevnar® E.A. Emini, Ph.D. Prevnar 13 R. Essner Introduction J. Victoria Welcome Tygacil® J.S. Camardo, M.D. Torisel™ Lybrel™ G. Constantine, M.D. Aprela™ / Viviant™ J.S. Camardo, M.D. Methylnaltrexone R.M. Poole, M.D., FACP Bifeprunox J.M. Mahady Pristiq™ B. Poussot Conclusion and Q&A Key Registration Submissions R.R. Ruffolo, Jr., Ph.D. Mid-Pipeline Review
  • 3. Introduction 5 Robert Essner Chairman and Chief Executive Officer, Wyeth
  • 4. Wyeth Past Business Performance 7% 3% 9% 10% 8% Revenue Growth (in billions) 6 WHI
  • 5. Wyeth Past Business Performance 11% 15% 2% 10% 7% EPS* Growth 7 WHI July Guidance * Before Certain Significant items
  • 6. EPS Continues to Grow in 2006 12% 11% 15% 2% 10% 7% EPS* Growth 8 WHI +** July Guidance * Before Certain Significant items ** When Adjusted for Stock Option Expensing in 2005